Company Data
InMed Pharmaceuticals Inc.
Ticker
INM
Current Price
$3.12 -7.96%
Market Cap
$2.1M
Price Target
Refer to Report
Volume
36.2K
52wk Range
$2.414 - $15.696
Overview
InMed Pharmaceuticals Inc is a Canada based pre-clinical stage biopharmaceutical company. The company is engaged in the research and development of novel, cannabinoid-based therapies combined with drug delivery systems. It is focused on the treatment of diseases including pain and inflammation, dermatology, Orofacial Pain, Glaucoma, ocular, CNS, respiratory, metabolic diseases, and others.